Moneycontrol PRO
HomeNewsAarey drugs and pharmaceuticals

Aarey Drugs And Pharmaceuticals

Jump to
  • Aarey Drugs Standalone September 2024 Net Sales at Rs 105.14 crore, up 81.81% Y-o-Y

    Aarey Drugs Standalone September 2024 Net Sales at Rs 105.14 crore, up 81.81% Y-o-Y

  • Aarey Drugs Standalone June 2024 Net Sales at Rs 126.91 crore, up 149.06% Y-o-Y

    Aarey Drugs Standalone June 2024 Net Sales at Rs 126.91 crore, up 149.06% Y-o-Y

  • Aarey Drugs Standalone March 2024 Net Sales at Rs 210.35 crore, up 32.98% Y-o-Y

    Aarey Drugs Standalone March 2024 Net Sales at Rs 210.35 crore, up 32.98% Y-o-Y

  • Aarey Drugs Standalone December 2023 Net Sales at Rs 76.48 crore, up 22.42% Y-o-Y

    Aarey Drugs Standalone December 2023 Net Sales at Rs 76.48 crore, up 22.42% Y-o-Y

  • Aarey Drugs Standalone September 2023 Net Sales at Rs 57.83 crore, down 24.17% Y-o-Y

    Aarey Drugs Standalone September 2023 Net Sales at Rs 57.83 crore, down 24.17% Y-o-Y

  • Aarey Drugs Standalone June 2023 Net Sales at Rs 50.96 crore, down 56.57% Y-o-Y

    Aarey Drugs Standalone June 2023 Net Sales at Rs 50.96 crore, down 56.57% Y-o-Y

  • Aarey Drugs Standalone March 2023 Net Sales at Rs 158.18 crore, up 31.55% Y-o-Y

    Aarey Drugs Standalone March 2023 Net Sales at Rs 158.18 crore, up 31.55% Y-o-Y

  • Aarey Drugs Standalone December 2022 Net Sales at Rs 62.47 crore, down 55.46% Y-o-Y

    Aarey Drugs Standalone December 2022 Net Sales at Rs 62.47 crore, down 55.46% Y-o-Y

  • Aarey Drugs Standalone June 2022 Net Sales at Rs 117.34 crore, up 20.33% Y-o-Y

    Aarey Drugs Standalone June 2022 Net Sales at Rs 117.34 crore, up 20.33% Y-o-Y

  • Aarey Drugs Standalone December 2021 Net Sales at Rs 140.27 crore, up 76.11% Y-o-Y

    Aarey Drugs Standalone December 2021 Net Sales at Rs 140.27 crore, up 76.11% Y-o-Y

  • Aarey Drugs Standalone June 2021 Net Sales at Rs 97.52 crore, up 286.7% Y-o-Y

    Aarey Drugs Standalone June 2021 Net Sales at Rs 97.52 crore, up 286.7% Y-o-Y

  • Elara India offloads more shares in Aarey Drugs, BNP Paribas acquires stake in IDFC

    Elara India offloads more shares in Aarey Drugs, BNP Paribas acquires stake in IDFC

    BNP Paribas Arbitrage has acquired 1 crore shares in IDFC at Rs 18.45 per share on the NSE.

  • FPIs sell 1.2% stake in Aarey Drugs, HT Media offloads more shares in JHS Svendgaard

    FPIs sell 1.2% stake in Aarey Drugs, HT Media offloads more shares in JHS Svendgaard

    Pace Stock Broking Services acquired 6,55,314 shares in IndoStar Capital Finance at Rs 285.05 per share on the NSE and 7,45,264 shares at Rs 285.04 per share on the BSE.

  • Aarey Drugs shares crack 11% after LTS Investment Fund exits

    Aarey Drugs shares crack 11% after LTS Investment Fund exits

    LTS Investment Fund offloaded its entire 4.13 percent stake in three consecutive days.

  • Aarey Drugs Standalone March 2019 Net Sales at Rs 137.31 crore, up 17.52% Y-o-Y

    Aarey Drugs Standalone March 2019 Net Sales at Rs 137.31 crore, up 17.52% Y-o-Y

  • Aarey Drugs Standalone December 2018 Net Sales at Rs 78.44 crore, down 12.42% Y-o-Y

    Aarey Drugs Standalone December 2018 Net Sales at Rs 78.44 crore, down 12.42% Y-o-Y

  • Aarey Drugs Standalone September 2018 Net Sales at Rs 71.64 crore, up 3.57% Y-o-Y

    Aarey Drugs Standalone September 2018 Net Sales at Rs 71.64 crore, up 3.57% Y-o-Y

  • Aarey Drugs rises 4% on first commercial export order win

    Aarey Drugs rises 4% on first commercial export order win

    The company will execute the said order by June 30, 2017.

  • Stocks in news: Axis, Tata Motors, Sun Pharma, IRB, Fortis, MEP

    Stocks in news: Axis, Tata Motors, Sun Pharma, IRB, Fortis, MEP

    Axis Bank | Tata Motors | Sun Pharma | IRB Infrastructure | Sunteck Realty | NIIT | Fortis Healthcare | Abbot India | APL Apollo Tubes | Aarey Drugs | PAE | MEP Infra and Bajaj Finance are stocks, which are in the news today.

  • DCB Bank, NIIT Tech, Crisil in focus post Q2 nos

    DCB Bank, NIIT Tech, Crisil in focus post Q2 nos

    Some of the stocks that should be on your radar are: Essar, NTPC, DCB Bank, NIIT Technologies, CRISIL, New Delhi Television, Aarey Drugs and Pharmaceuticals.

  • Aarey Drugs standalone Dec '15 sales at Rs 63.33 crore

    Aarey Drugs standalone Dec '15 sales at Rs 63.33 crore

    Aarey Drugs and Pharmaceuticals has reported a sales total income from operations of Rs 63.33 crore and a net profit of Rs 0.20 crore for the quarter ended Dec '15

  • Aarey Drugs standalone Sep '15 sales at Rs 32.21 crore

    Aarey Drugs standalone Sep '15 sales at Rs 32.21 crore

    Aarey Drugs and Pharmaceuticals has reported a sales total income from operations of Rs 32.21 crore and a net profit of Rs 0.45 crore for the quarter ended Sep '15

  • Aarey Drugs standalone Jun '15 sales at Rs 41.85 crore

    Aarey Drugs standalone Jun '15 sales at Rs 41.85 crore

    Aarey Drugs and Pharmaceuticals has reported a sales total income from operations of Rs 41.85 crore and a net profit of Rs 0.60 crore for the quarter ended Jun '15

  • Emkay Global settles case with Sebi

    Emkay Global settles case with Sebi

    Sebi had launched adjudication proceedings in April 2013 against Emkay Global Financial Services Ltd in a case relating to alleged violation of the Code of Conduct for Stock Brokers and the Sebi regulations for stock brokers and sub brokers. These related to Emkay's dealings in shares of Aarey Drugs and Pharmaceuticals Ltd.

  • Aarey Drugs standalone Mar '15 sales at Rs 77.19 crore

    Aarey Drugs standalone Mar '15 sales at Rs 77.19 crore

    Aarey Drugs and Pharmaceuticals has reported a sales total income from operations of Rs 77.19 crore and a net profit of Rs 0.08 crore for the quarter ended Mar '15

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347